LEP and breast carcinoma: LDFI peptide significantly reduced exosome secretion in both MCF-7 and MDA-MB-231 breast cancer cells, demonstrating the leptin/leptin receptor/Hsp90 axis as an important regulator of exosome generation in mammary carcinoma cells [125].